Figure 6
Figure 6. Effect of inhibiting RLC phosphorylation stimulated by anti-β2GPI antibodies on endothelial microparticle release and cell surface E-selectin expression. Endothelial cells were incubated in medium alone or with β2GPI and control or anti-β2GPI antibodies for 8 hours and the release of microparticles and cell surface expression of E-selectin quantified as described in “Materials and methods.” Inhibitors used include Y-27632 (5 µM), ML-7 (5 µM), or blebbistatin (50 µM). Inhibitors were used alone or in combination, as depicted in abscissa of each graph. (A,C,E,G) The effects of inhibitors or specific siRNA on endothelial cell microparticle release induced by anti-β2GPI antibodies. (B,D,F,H) The effects of inhibitors or specific siRNA on endothelial E-selectin expression induced by anti-β2GPI antibodies.

Effect of inhibiting RLC phosphorylation stimulated by anti-β2GPI antibodies on endothelial microparticle release and cell surface E-selectin expression. Endothelial cells were incubated in medium alone or with β2GPI and control or anti-β2GPI antibodies for 8 hours and the release of microparticles and cell surface expression of E-selectin quantified as described in “Materials and methods.” Inhibitors used include Y-27632 (5 µM), ML-7 (5 µM), or blebbistatin (50 µM). Inhibitors were used alone or in combination, as depicted in abscissa of each graph. (A,C,E,G) The effects of inhibitors or specific siRNA on endothelial cell microparticle release induced by anti-β2GPI antibodies. (B,D,F,H) The effects of inhibitors or specific siRNA on endothelial E-selectin expression induced by anti-β2GPI antibodies.

Close Modal

or Create an Account

Close Modal
Close Modal